Pharmacology and Clinical Pharmacy Research
Vol 2, No 1

Binding Modes of Doxorubicin Compared to Estratetrol and Tamoxifen

Muchammad R. Ghozaly (Unknown)
Ellin Febrina (Unknown)
Achmad Zaenudin (Unknown)



Article Info

Publish Date
01 Apr 2017

Abstract

Doxorubicin, a compound isolated from Streptomyces peucetius var Caesius, is commonlyused in the treatment of breast cancer. This drug works by interacting on human nucleicacids. This work was aimed to study the binding modes of doxorubicin with estrogen receptoralpha (ERα). Estratetrol and tamoxifen were used as natural ligand and standard drug,respectively. Molecular docking simulations was performed by AutoDock v.3.05 using minimumcoordinates -34, -6, -15 (x, y, z) and the maximum coordinates -13, 13, 3 (x, y, z).Tamoxifen formed one hydrogen bond with Glu353 (Ki=3.78 μM); estratetrol binds to Glu-353, Arg394, Gly521, and His524 (Ki=0.01 μM). Doxorubicin only formed one hydrogenbond with Ser317 (Ki=N/A). In conclusion, doxorubicin could not interact appropriatelywith ERα due to its voluminioues structure which hinder its entrance to binding pocket ofthe macromolecule.Keywords: doxorubicin, estrogen receptor alpha.

Copyrights © 0000






Journal Info

Abbrev

pcpr

Publisher

Subject

Medicine & Pharmacology

Description

Pharmacology and Clinical Pharmacy Research (PCPR) is an international, peer-reviewed journal, publishing original research, review, case reports, and commentaries on all aspects of pharmacology and clinical pharmacy. The journal aims to contribute to the scientific committee by publishing the high ...